UP!

ABC $96.14   View long term graphs

AmerisourceBergen Corporation
Type
Public
Traded as NYSE: ABC
S&P 500 Component
Industry Pharmaceutical
Founded Merger between AmeriSource Health and Bergen Brunswig in 2001
Headquarters Conshohocken, Pennsylvania, U.S.
Area served
North America
United Kingdom
Key people
Richard C. Gozon
(Chairman)
Steven H. Collis
(President), (CEO) & (Director)
Products Pharmaceuticals and pharmacy services
Revenue IncreaseUS$135.9 billion (2015)
Operating income
DecreaseUS$386 million (2015)
Net income
DecreaseUS$-134 million (2015)
Total assets IncreaseUS$27.73 billion (2015)
Total equity DecreaseUS$633 million (2015)
Number of employees
16,500 (2015)
Website AmerisourceBergen.com

AmerisourceBergen Corporation is an American drug wholesale company that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. They provide drug distribution and related services designed to reduce costs and improve patient outcomes, distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to a wide variety of health care providers located throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as skilled nursing and assisted living centers. They also provide pharmaceuticals and pharmacy services to long-term care, workers' compensation and specialty drug patients.

AmerisourceBergen is a market leader in pharmaceutical distribution handling about 20% of all of the pharmaceuticals sold and distributed throughout the country and ranked 16th on the Fortune 500 list for 2015 with over $100 Billion in annual revenue. In terms of revenue (79.49 billion in 2012) the firm is the largest based in Pennsylvania.

AmerisourceBergen was formed in 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. AmeriSource and Bergen were both successful pharmaceutical distributors that served similar markets but covered somewhat different geographies. Bringing the two together gave the company a strong national presence that was geared especially towards serving independent community pharmacies, regional retail chain pharmacies, hospitals, physician offices, clinics and other alternate care facilities.

AmerisourceBergen has 26 pharmaceutical distribution centers in the US, nine distribution centers in Canada, four specialty distribution centers in the US, and over 1 million square feet of packaging production capacity in the US and the UK. With the addition of World Courier, the largest specialty courier company in the world, over 150 company-owned offices around the globe were added to the company.

In 2012 the state of West Virginia filed a lawsuit against AmerisourceBergen On 5/17/2015, the West Virginia Gazette reported, "AmerisourceBergen, the nation’s third largest drug wholesaler, shipped 80.3 million hydrocodone pills and 38.4 million oxycodone pills to West Virginia over the five-year span — the highest totals for both drugs by any company named in the state’s lawsuit, according to the filing. and that "The lawsuit alleges that the companies have helped fuel the state’s pain pill epidemic by shipping excessive amounts of prescription painkillers to southern West Virginia pharmacies."

AmerisourceBergen operates its pharmaceutical distribution business under four primary units: AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS) and World Courier. In March 2016 Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company.

Good Neighbor Pharmacy is an American retailers' cooperative network of more than 3,400 independently owned and operated pharmacies. It has a business affiliation with AmerisourceBergen, which sponsors the network and owns the name "Good Neighbor Pharmacy" Good Neighbor Pharmacy is the sponsor for "Thought Spot" the annual trade show held in Las Vegas.

ThoughtSpot is a four-day trade show put on by Good Neighbor Pharmacy held in or around July in Las Vegas aimed for and limited to community and independent pharmacies.

Exhibitors are represented throughout the healthcare industry including, brand name, generic and over the counter products. ThoughtSpot 2013 was hosted at the MGM Grand, Las Vegas from July 24 to July 27. Special guest musical performance by Bret Michaels capped off the week on July 27 at a special attendee-only closing event.

KnowledgeDriven is a resource site sponsored by AmerisourceBergen.

News

AmerisourceBergen Corporation -1.48% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2021 2021-01-28 Future report Set alerts
Q4 2020 2020-11-05 Future report Set alerts
Q3 2020 2020-08-05 1.85 1.41
Q2 2020 2020-05-07 2.40 4.64
Q1 2020 2020-01-30 1.76 0.90
Q4 2019 2019-11-07 1.61 0.63
Q3 2019 2019-08-01 1.76 1.43
Q2 2019 2019-05-02 2.11 0.13
Q1 2019 2019-01-31 1.60 1.84
Q4 2018 2018-11-06 1.45 1.07

Ratings

2016-06-07 Reiterated Rating Bank of America Neutral
2016-06-07 Reiterated Rating Bank of America Corp. Neutral
2016-06-04 Reiterated Rating Argus Buy
2016-06-01 Downgrade Raymond James Outperform to Market Perform
2016-06-01 Downgrade Raymond James Financial Inc. Outperform to Market Perform
2016-05-06 Boost Price Target RBC Capital Outperform $85.00 to $100.00
2016-05-06 Lower Price Target FBR & Co. Market Perform $100.00 to $84.00
2016-05-06 Reiterated Rating Robert W. Baird Hold
2016-05-06 Boost Price Target Royal Bank Of Canada Outperform $85.00 to $100.00
2016-05-06 Lower Price Target FBR & Co Market Perform $100.00 to $84.00
2016-05-05 Downgrade Avondale Partners Outperform to Market Perform
2016-04-18 Initiated Coverage Avondale Partners Outperform $111.00
2016-03-15 Initiated Coverage Credit Suisse Outperform $103.00
2016-03-15 Boost Price Target Cowen and Company $95.00 to $98.00
2016-03-15 Initiated Coverage Credit Suisse Group AG Outperform $103.00
2016-02-06 Reiterated Rating Barclays Hold
2016-02-06 Reiterated Rating Barclays PLC Hold
2016-02-05 Lower Price Target Robert W. Baird Equal Weight to Neutral $108.00 to $99.00
2016-02-05 Reiterated Rating Deutsche Bank Hold $103.00 to $96.00
2016-02-05 Lower Price Target Barclays Equal Weight $100.00 to $90.00
2016-02-05 Lower Price Target RBC Capital Outperform $120.00 to $100.00
2016-02-05 Reiterated Rating Deutsche Bank AG Hold $103.00 to $96.00
2016-02-04 Lower Price Target FBR & Co. Mkt Perform $110.00 to $100.00
2016-01-29 Lower Price Target Leerink Swann Outperform $129.00 to $105.00
2016-01-27 Lower Price Target Deutsche Bank Hold $109.00 to $103.00
2016-01-12 Reiterated Rating Robert W. Baird Neutral $113.00 to $108.00
2016-01-06 Downgrade Raymond James Outperform to Market Perform
2015-11-18 Lower Price Target Mizuho Neutral $112.00 to $105.00
2015-11-17 Initiated Coverage Credit Suisse Outperform $121.00
2015-11-16 Upgrade Morgan Stanley Underweight to Equal Weight
2015-11-01 Reiterated Rating Deutsche Bank Hold $109.00
2015-10-30 Boost Price Target Cowen and Company $107.00 to $109.00
2015-10-30 Lower Price Target Robert W. Baird $115.00 to $113.00
2015-10-21 Lower Price Target Cowen and Company $119.00 to $107.00
2015-10-12 Reiterated Rating Deutsche Bank Hold $106.00
2015-10-07 Lower Price Target Raymond James Outperform $130.00 to $110.00
2015-10-07 Reiterated Rating Evercore ISI Hold
2015-10-07 Reiterated Rating RBC Capital Outperform $130.00
2015-10-06 Reiterated Rating Cowen and Company Hold
2015-10-02 Downgrade Morgan Stanley Equal Weight to Underweight $120.00 to $93.00
2015-07-16 Boost Price Target KeyBanc Overweight $61.00 to $63.00
2015-07-16 Boost Price Target KeyCorp Overweight $61.00 to $63.00
2015-05-18 Downgrade Cowen and Company Outperform to Market Perform $121.00
2015-05-13 Boost Price Target Argus Buy $104.00 to $135.00
2015-05-01 Boost Price Target Barclays Equal Weight $90.00 to $93.00
2015-05-01 Boost Price Target RBC Capital Outperform $120.00 to $130.00
2015-05-01 Boost Price Target FBR & Co. Market Perform $108.00 to $115.00
2015-05-01 Boost Price Target Mizuho Buy $110.00 to $112.00
2015-04-23 Boost Price Target RBC Capital Outperform $110.00 to $120.00
2015-03-20 Boost Price Target FBR & Co. Hold $100.00 to $108.00
2015-03-13 Reiterated Rating Mizuho Hold $94.00 to $110.00
2015-03-03 Boost Price Target RBC Capital Outperform $106.00 to $110.00
2015-01-29 Boost Price Target Deutsche Bank Hold $89.00 to $96.00
2015-01-29 Boost Price Target Credit Suisse Outperform $95.00 to $108.00
2015-01-29 Boost Price Target RBC Capital Outperform $95.00 to $106.00
2015-01-29 Boost Price Target FBR & Co. Market Perform $90.00 to $100.00
2015-01-29 Boost Price Target Mizuho Neutral $87.00 to $94.00
2015-01-13 Boost Price Target Cowen and Company Outperform $93.00 to $100.00
2015-01-08 Reiterated Rating JPMorgan Chase & Co. Hold $89.00 to $92.00
2015-01-08 Downgrade Barclays Overweight to Equal Weight $89.00 to $90.00
2014-11-21 Downgrade FBR & Co. Outperform to Market Perform $90.00
2014-11-04 Reiterated Rating Credit Suisse Outperform $83.00 to $95.00
2014-10-31 Boost Price Target Mizuho Neutral $75.00 to $87.00
2014-10-31 Downgrade ISI Group Strong Buy to Buy $89
2014-10-31 Reiterated Rating Barclays Overweight $83.00 to $89.00
2014-10-31 Reiterated Rating Deutsche Bank Hold $80.00 to $86.00
2014-10-31 Reiterated Rating FBR & Co. Outperform $83.00 to $90.00
2014-10-31 Reiterated Rating Citigroup Inc. Buy $89.00 to $98.00
2014-10-31 Boost Price Target Cowen and Company Outperform $85.00 to $93.00
2014-10-31 Boost Price Target RBC Capital Outperform $88.00 to $95.00
2014-10-31 Downgrade Evercore ISI Strong-Buy to Buy $89.00
2014-10-16 Initiated Coverage RBC Capital Outperform $88.00
2014-07-25 Reiterated Rating S&P Equity Research Strong-Buy
2014-07-25 Reiterated Rating Raymond James Outperform $74.00 to $85.00
2014-07-25 Reiterated Rating Deutsche Bank Hold $73.00 to $80.00
2014-07-25 Reiterated Rating Citigroup Inc. Buy $83.00 to $89.00
2014-07-25 Reiterated Rating Barclays Overweight $77.00 to $83.00
2014-07-25 Boost Price Target FBR & Co. Outperform $75.00 to $83.00
2014-07-24 Boost Price Target Mizuho Neutral $72.00 to $75.00
2014-07-10 Boost Price Target Robert W. Baird Neutral $70.00 to $74.00
2014-04-25 Reiterated Rating Deutsche Bank Hold $73.00
2014-04-25 Lower Price Target Cowen and Company $80.00 to $75.00
2014-04-25 Lower Price Target Raymond James $79.00 to $74.00
2014-04-24 Lower Price Target Mizuho Neutral $75.00 to $72.00
2014-04-10 Upgrade FBR Capital Mkt Perform to Outperform $75
2014-04-10 Upgrade Evercore ISI Neutral to Buy $74.00
2014-04-09 Resumed FBR Capital Outperform $75
2014-04-09 Upgrade FBR & Co. Market Perform to Outperform $75.00
2014-03-12 Downgrade Goldman Sachs Buy to Neutral $78.00 to $75.00
2014-03-05 Initiated Coverage Barclays Overweight $77.00
2014-02-18 Initiated Coverage Citigroup Inc. Hold to Buy
2014-01-24 Boost Price Target Argus Buy $73.00 to $83.00
2014-01-24 Boost Price Target Raymond James $73.00 to $79.00
2014-01-24 Boost Price Target FBR & Co. Market Perform $72.00 to $75.00
2013-12-17 Boost Price Target Deutsche Bank Buy $72.00 to $78.00
2013-11-20 Initiated Coverage Deutsche Bank Hold $75.00
2013-11-08 Boost Price Target Argus Buy $65.00 to $73.00
2013-11-04 Boost Price Target Mizuho Neutral $57.00 to $67.00
2013-11-01 Reiterated UBS Neutral $57 to $67
2013-11-01 Boost Price Target Raymond James Outperform $63.00 to $73.00
2013-11-01 Boost Price Target Credit Suisse Outperform $65.00 to $73.00
2013-11-01 Boost Price Target Cowen and Company Outperform $69.00 to $78.00
2013-10-29 Initiated FBR Capital Mkt Perform $72
2013-10-29 Initiated Coverage FBR & Co. Market Perform $72.00
2013-10-15 Boost Price Target Robert W. Baird Neutral $57.00 to $61.00
2013-10-14 Boost Price Target Evercore ISI Neutral $59.00 to $65.00
2013-09-18 Initiated Coverage Sterne Agee CRT Buy $80.00
2013-07-15 Reiterated Mizuho Neutral $45 to $57
2013-04-26 Reiterated ISI Group Neutral $54 to $58
2013-04-26 Downgrade Robert W. Baird Outperform to Neutral $59 to $57
2013-03-20 Reiterated Argus Buy $50 to $60
2013-03-20 Downgrade ISI Group Buy to Neutral $54
2013-03-18 Downgrade UBS Buy to Neutral
2013-03-05 Downgrade ISI Group Strong Buy to Buy $51.50 to $53
2013-01-23 Reiterated UBS Buy $45 to $51
2013-01-04 Downgrade Mizuho Buy to Neutral $45
2016-06-07 Reiterated Rating Bank of America Neutral
2016-06-07 Reiterated Rating Bank of America Corp. Neutral
2016-06-04 Reiterated Rating Argus Buy
2016-06-01 Downgrade Raymond James Outperform to Market Perform
2016-06-01 Downgrade Raymond James Financial Inc. Outperform to Market Perform

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Walgreens Boots Alliance, Inc. 14.85%  (34157955) ABC / WBA /
COLLIS STEVEN H President & CEO 0.12%  (266575) ABC / THOR /
GOZON RICHARD C 0.02%  (51484) ABC / TGI /
Chou John G. Executive Vice President 0.02%  (51288) ABC /
Guttman Tim G. Chief Financial Officer 0.02%  (50671) ABC /
Howell Peyton R Senior Vice President 0.02%  (47989) ABC /
Frary James Senior Vice President 0.02%  (38755) ABC /
LONG MICHAEL J 0.02%  (34685) ABC / ARW /
COTROS CHARLES H 0.01%  (26773) ABC /
HENNEY JANE E MD 0.01%  (15045) ABC / CBST / CI /
Clark Gina Executive Vice President 0.01%  (13614) ABC /
GOCHNAUER RICHARD W 0.01%  (13225) ABC / UGI /
McGee Henry Wadsworth III 0.01%  (12719) ABC / GCI /
Mauch Robert P. Executive Vice President 0.01%  (12123) ABC /

Comments